Keyphrases
Inflammatory Bowel Disease
67%
Pediatric Inflammatory Bowel Disease
46%
Crohn's Disease
33%
Randomized Controlled Trial
26%
Celiac Disease
24%
Porto
22%
Pediatric
22%
ESPGHAN
19%
Pediatric Patients
18%
Remission
17%
Body Mass Index
14%
Ulcerative Colitis
14%
Polyposis Syndromes
13%
Working Diagnosis
13%
Israel
13%
Ustekinumab
12%
Juvenile Polyposis Syndrome
12%
Preterm Infants
12%
Newly Diagnosed
11%
Clinical Remission
11%
Pediatric Ulcerative Colitis
10%
Position Paper
10%
Vedolizumab
10%
Colorectal Cancer
10%
Paediatric Gastroenterology
10%
Posttraumatic Stress Disorder
10%
Vitamin D
10%
Polyposis
9%
Pediatric IBD
9%
Stress Response
9%
Adalimumab
9%
Acute Pancreatitis
9%
Biallelic Mismatch Repair Deficiency
9%
Deficiency Diseases
9%
Pediatric Feeding Disorders
9%
Disease Exacerbation
9%
Disease Course
9%
Anti-tumor Necrosis Factor (anti-TNF)
8%
Gastroenterology & Hepatology
8%
Familial Adenomatous Polyposis
8%
C-reactive Protein
8%
BMPR2
8%
Disease Activity
8%
Nutritional Intervention
8%
High Risk
8%
Endoscopy
8%
Hospitalization
7%
Pediatric Crohn's Disease
7%
Clock Genes
7%
Pediatric Hepatology
7%
Medicine and Dentistry
Pediatrics
100%
Inflammatory Bowel Disease
78%
Adolescent
28%
Crohn's Disease
24%
Coeliac Disease
22%
Polyposis
22%
Disease
22%
Ulcerative Colitis
20%
Body Mass Index
14%
Randomized Controlled Trial
13%
DNA Mismatch Repair
12%
Symptom
11%
Colitis
10%
Polyp
10%
Pediatric Gastroenterology
9%
Cytomegalovirus
9%
Acute Pancreatitis
9%
Juvenile Polyposis Syndrome
9%
Enteric Feeding
9%
Endoscopy
9%
Pediatrics Patient
9%
Disease Exacerbation
8%
Vedolizumab
8%
Ustekinumab
8%
Prevalence
8%
Disease Course
8%
Familial Adenomatous Polyposis
8%
Hepatology
8%
Tumor Necrosis Factor
7%
Patient with Inflammatory Bowel Disease
7%
Colorectal Cancer
7%
Pediatric Nutrition
7%
Elimination Diet
6%
Gastrointestinal Endoscopy
6%
Biological Therapy
6%
Adverse Event
6%
Mesalazine
6%
Observational Study
6%
Cytomegalovirus Infection
6%
Tertiary Care
6%
Lactose
6%
Feeding Disorder
6%
Helicobacter Infection
6%
Bowel Resection
6%
Gene Disruption
6%
Disease Activity
6%
Primary Health Care
5%
C Reactive Protein
5%
Hazard Ratio
5%
Retinol Deficiency
5%
